SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Key Financial Information of the Segments

The following table presents key financial information for each of the Company's reportable segments. During the year ended December 31, 2019, the Company entered into the China JV and HK JV with Harbin to operate its e-commerce and retail business in China and a strategic joint venture with IVC regarding the Company's manufacturing business which significantly impacted the operating results within the International and Manufacturing / Wholesale segments. During the year ended December 31, 2018, the Company recorded long-lived asset impairments of $38.2 million which significantly impacted the U.S. and Canada segment by $36.1 million and the International segment by $2.1 million. During the year ended December 31, 2017, the Company recorded long-lived asset impairments of $457.8 million which significantly impacted the U.S. and Canada segment by $412.5 million, the Manufacturing / Wholesale segment by $24.3 million, the International segment by $1.6 million and Lucky Vitamin within Other by $19.4 million. Refer to Note 6, "Goodwill and Intangible Assets" and Note 7, "Property, Plant and Equipment, Net" for more information.

	Year ended December 31,
	2019			2018			2017
	(in thousands)
Revenue:
U.S. and Canada	$	1,822,327		$	1,951,220		$	2,018,931
International	158,167			191,409			177,778
Manufacturing / Wholesale
Intersegment revenues	35,505			264,211			231,495
Third party	87,694			210,894			218,071
Subtotal Manufacturing / Wholesale	123,199			475,105			449,566
Total reportable segment revenues	2,103,693			2,617,734			2,646,275
Other	—			—			66,182
Elimination of intersegment revenues	(35,505		)	(264,211		)	(231,495		)
Total revenue	$	2,068,188		$	2,353,523		$	2,480,962
Operating income (loss):
U.S. and Canada	$	151,037		$	94,663		$	(244,104	)
International	55,380			60,367			60,987
Manufacturing / Wholesale	41,153			62,861			49,175
Total reportable segment operating income (loss)	247,570			217,891			(133,942		)
Corporate costs	(98,221		)	(105,378		)	(102,114		)
Loss on net asset exchange for the formation of the joint ventures	(21,293		)	—			—
Other loss, net	(3,313		)	(160		)	(20,760		)
Unallocated corporate costs, loss on net asset exchange or sale and other loss, net	(122,827		)	(105,538		)	(122,874		)
Total operating income (loss)	124,743			112,353			(256,816		)
Interest expense, net	106,709			127,080			64,221
Gain on convertible debt and debt refinancing costs	(3,214		)	—			(10,996		)
Loss on debt refinancing	—			16,740			—
Loss (gain) on forward contracts for the issuance of convertible preferred stock	16,787			(88,942		)	—
Income (loss) before income taxes	$	4,461		$	57,475		$	(310,041	)

	Year ended December 31,
	2019		2018		2017
Depreciation and amortization:	(in thousands)
U.S. and Canada	$	23,779	$	27,685	$	35,571
International	2,292		2,487		2,455
Manufacturing / Wholesale	3,056		9,790		10,238
Corporate and other	6,295		7,143		8,545
Total depreciation and amortization	$	35,422	$	47,105	$	56,809
Capital expenditures:
U.S. and Canada	$	10,985	$	10,705	$	20,614
International	191		759		277
Manufacturing / Wholesale	184		3,459		2,862
Corporate and Other	3,791		4,058		8,370
Total capital expenditures	$	15,151	$	18,981	$	32,123

	As of December 31
	2019		2018
Total assets:	(in thousands)
U.S. and Canada	$	1,142,588	$	867,977
International	201,996		200,128
Manufacturing / Wholesale	156,043		288,163
Corporate and other	149,960		171,582
Total assets (1)	$	1,650,587	$	1,527,850
Property, plant, and equipment, net:
United States	$	83,899	$	150,689
Foreign	3,017		4,406
Total property, plant and equipment, net	$	86,916	$	155,095

(1) Total assets as of December 31, 2019 included $350.6 million of right-of-use asset in connection with the adoption of ASC 842